Home › Ovarian Epithelial Carcinoma › Connecticut › New Haven
Ovarian Epithelial Carcinoma clinical trials in New Haven, CT
4 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecruitingPhase 2
- Yale University School of Medicine /ID# 275794, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecruitingPhase 1/2
- Yale University, Yale Cancer Center, New Haven
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RecruitingPhase 2
- Smilow Cancer Hospital at Yale - New Haven, New Haven
Ovarian Epithelial Carcinoma trials in other cities
- Boston, MA8 studies
- Durham, NC8 studies
- New York City, NY7 studies
- San Diego, CA7 studies
- Chicago, IL7 studies
- Baltimore, MD6 studies
- Cleveland, OH6 studies
- Philadelphia, PA6 studies
- Houston, TX6 studies
- Salt Lake City, UT5 studies
- Portland, OR5 studies
- Minneapolis, MN5 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.